Inozyme Investors

24 investors on Angel Roster list Inozyme in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, France and Canada.

Investors are matched on the company name in their portfolio, so companies that share the name Inozyme can appear together.

Investors listed
24
With verified email
58%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 24 Inozyme investors

The most complete profiles first. Showing 24 of 24.

  • Amar PatelVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Brian LiuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Karthik BolisettyVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Michael WertVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Sonia ParekhVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Garrett HowardVerified

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Jason P. HaflerVerified

    Corporate Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Josh RichardsonVerified

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Laia CrespoVerified

    Venture Capital, Corporate Venture Capital, Investor · France

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Maxwell Bikoff

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Carolyn Helms

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • Daniel Mansuri

    Corporate Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Marc

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • Zander Liem

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • Rob HopfnerVerified

    Venture Capital, Investor · United States

    SeedBiotechnologyPharmaceuticals

    Portfolio: Civitas Therapeutics, Inozyme, Rallybio

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Inozyme investors are on Angel Roster?

Angel Roster lists 24 Inozyme investors. 14 of them (58%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (22), Private Equity Firms (5) and Corporate Venture Capital Firms (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Inozyme investors invest in?

Among those that list a stage, the most common are Seed (11) and Series B (1).

Where are Inozyme investors based?

Most are based in the United States (22), France (1) and Canada (1).

Which companies have Inozyme investors backed?

The most-backed portfolio companies among them are Civitas Therapeutics (21), Neurana Pharmaceuticals (20), Checkmate Pharmaceuticals (20), Vera Therapeutics (20) and Amphora Medical (11).

How do I contact Inozyme investors?

Create a free Angel Roster account to search and filter all 24, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.